NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/07/2022
Back to search
Official data from USPTO
BEYONDSPRING PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
06/07/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
12/22/2017
Registration date
06/07/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/07/2022
Last transaction
06/07/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/20/2022
First use in commerce
04/20/2022
Drawing code
3
Owner type
03
Owner location
New York, NY, US
Examiner
HARDY LUDLOW, TARAH KIM
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "BEYONDSPRING" above the wording "PHARMACEUTICALS." To the left of the words is a pictorial depiction of a tree.
Holders and representatives
Holders
BeyondSpring Pharmaceuticals, Inc.
Representatives
Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceuticals, namely, anti-inflammatories; pharmaceuticals, medications and preparations for the prevention and treatment of skin conditions, cancer and disorders of the nervous, immune and pulmonary systems; medical vials and other such containers filled with pharmaceutical preparations for treatment of skin conditions, cancer and disorders of the nervous, immune and pulmonary systems
Class 42
pharmaceutical research; medical, scientific and pharmaceutical research in the field of skin treatment, cancer and the nervous, immune and pulmonary systems; biological research ; research and development of new pharmaceutical, and life science products; chemical research; biology research
Publications
History of USPTO decisions and trademark events.
57 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/07/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/04/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/03/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/02/2022
IUAF
USE AMENDMENT FILED
04/28/2022
EISU
TEAS STATEMENT OF USE RECEIVED
04/28/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2021
EX5G
SOU EXTENSION 5 GRANTED
11/08/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/08/2021
EXT5
SOU EXTENSION 5 FILED
11/03/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/03/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/01/2021
EX4G
SOU EXTENSION 4 GRANTED
04/29/2021
EXT4
SOU EXTENSION 4 FILED
04/29/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/29/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/24/2020
EX3G
SOU EXTENSION 3 GRANTED
10/22/2020
EXT3
SOU EXTENSION 3 FILED
10/22/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/22/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/23/2020
EX2G
SOU EXTENSION 2 GRANTED
04/21/2020
EXT2
SOU EXTENSION 2 FILED
04/21/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/21/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/11/2019
EX1G
SOU EXTENSION 1 GRANTED
07/09/2019
EXT1
SOU EXTENSION 1 FILED
07/09/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/09/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/07/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2019
PUBO
PUBLISHED FOR OPPOSITION
03/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/20/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/04/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/04/2019
ALIE
ASSIGNED TO LIE
02/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/22/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/22/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/22/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/16/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/20/2018
GNRT
NON-FINAL ACTION E-MAILED
07/20/2018
CNRT
NON-FINAL ACTION WRITTEN
07/20/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/18/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/17/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2018
GNRT
NON-FINAL ACTION E-MAILED
04/04/2018
CNRT
NON-FINAL ACTION WRITTEN
04/04/2018
DOCK
ASSIGNED TO EXAMINER
04/04/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/17/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2018
NWAP
NEW APPLICATION ENTERED
12/26/2017
Continuous trademark protection
Get notified about every new filing that threatens BEYONDSPRING PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.